Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyridoxine for Prevention of Capecitabine-induced Hand-Foot Syndrome
NCT00446147Phase 3Completed
- Sponsor
- Asan Medical Center
- Start
- Jun 2004
- Primary completion
- Dec 2006
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of pyridoxine in hand-foot syndrome (HFS), sponsored by Asan Medical Center. Started Jun 2004; status: completed.
02
Drugs
pyridoxine
03
Conditions
hand-foot syndrome (HFS)
Beyond the preview
Go deeper on NCT00446147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446147.